Investors

News & Press Release

  • 30.03.23

    SISRAM Medical Expands Footprint in Mainland China, Acquires Giant Medical Aesthetic Distributor – PhotonMed

  • 21.03.23

    Sisram Medical Announces 2022 Annual Results

  • 19.03.23

    Sisram Medical Ltd. to Announce Full Year 2022 Financial Results on March 21, 2023

  • 03.01.23

    Sisram Medical to Present Virtually at the 25th Annual Needham Growth Conference

  • 21.11.22

    Alma Academy was Successfully Held in Dubai with the Global Launch of Alma Duo

  • 10.11.22

    Sisram Medical Attends the Asia Summit On Global Health

  • 07.11.22

    Sisram Medical Participates in CIIE for Fifth Consecutive Year

  • 21.08.22

    Sisram Medical Ltd Announces 2022 Interim Results

  • 11.08.22

    Sisram Medical Ltd. to Hold First Half 2022 Financial Results Conference Call on August 22 at 8:30 a.m. ET

  • 28.06.22

    Sisram Medical’s associate company Tianjin JuveStar released Phase IIb result of lipolysis injection, reduction of submental fat by 15% through one treatment

52 week Range -
/